Personal Capital Advisors Corp increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 17.9% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 122,587 shares of the healthcare conglomerate’s stock after buying an additional 18,601 shares during the period. Personal Capital Advisors Corp’s holdings in UnitedHealth Group were worth $22,730,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of UNH. State Street Corp boosted its position in UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after buying an additional 1,122,534 shares in the last quarter. Legal & General Group Plc boosted its position in UnitedHealth Group by 5.4% in the first quarter. Legal & General Group Plc now owns 4,954,692 shares of the healthcare conglomerate’s stock valued at $812,630,000 after buying an additional 254,545 shares in the last quarter. Harris Associates L P boosted its position in UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock valued at $762,041,000 after buying an additional 14,489 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in UnitedHealth Group by 6.2% in the first quarter. UBS Asset Management Americas Inc. now owns 4,372,898 shares of the healthcare conglomerate’s stock valued at $717,199,000 after buying an additional 255,799 shares in the last quarter. Finally, American Century Companies Inc. boosted its position in UnitedHealth Group by 9.0% in the first quarter. American Century Companies Inc. now owns 4,022,002 shares of the healthcare conglomerate’s stock valued at $659,649,000 after buying an additional 333,338 shares in the last quarter. Institutional investors and hedge funds own 86.21% of the company’s stock.

Shares of UnitedHealth Group Incorporated (NYSE UNH) traded up 0.99% during midday trading on Thursday, reaching $197.82. 994,940 shares of the company’s stock were exchanged. The company’s 50-day moving average is $191.39 and its 200-day moving average is $177.02. UnitedHealth Group Incorporated has a one year low of $132.39 and a one year high of $198.39. The stock has a market cap of $191.26 billion, a P/E ratio of 23.77 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same period in the previous year, the company posted $1.96 earnings per share. UnitedHealth Group’s revenue for the quarter was up 7.7% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date is Thursday, September 7th. UnitedHealth Group’s payout ratio is presently 35.13%.

COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Shares Bought by Personal Capital Advisors Corp” was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-shares-bought-by-personal-capital-advisors-corp/1534559.html.

Several equities analysts have issued reports on UNH shares. Morgan Stanley upped their target price on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, June 28th. Sanford C. Bernstein restated an “outperform” rating and set a $190.00 target price on shares of UnitedHealth Group in a research note on Monday, July 10th. Deutsche Bank AG upped their target price on shares of UnitedHealth Group from $187.00 to $197.00 and gave the company a “buy” rating in a research note on Thursday, July 13th. Oppenheimer Holdings, Inc. restated an “outperform” rating and set a $205.00 target price (up previously from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Finally, Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday, May 19th. One equities research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $203.41.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the transaction, the director now directly owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the transaction, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. Insiders sold 30,540 shares of company stock valued at $5,748,970 over the last three months. 0.89% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.